Stout performed IPO readiness services for Coya Therapeutics, Inc., a biotechnology company. We assisted the client’s management team with the preparation of their financial statements, which included converting previously issued AICPA financial statements for PCAOB compliance, writing their management discussion and analysis (MD&A) and other financial sections of their S-1, and writing various technical accounting memorandums.

In addition to this, our complex security valuation experts helped the Company determine the fair value of its common stock and convertible debt securities leading up to the initial public offering in order to avoid any filing delays or cheap stock issues with the SEC.

Lastly, we began the process of remediating the companys material weakness in its internal controls by implementing a proper controls environment for a publicly traded company.